Intravenous Infusions PLC (IIL)
Key Metrics
- Market Cap
- --
- EPS
- --
- P/E Ratio
- --
- Shares Outstanding
- --
- Dividend Yield
- --
- P/B Ratio
- --
- PEG Ratio
- --
Performance
Dividends
Intravenous Infusions PLC has not paid any dividends in the last 5 years.
No dividend history available.
Liquidity
High- Avg Daily Volume
- 884.9K
- Trading Days
- 60
- Zero-Trade Days
- 26
- Inactive Rate
- 43%
Assumes 25% participation rate of daily volume. Actual time may vary.
Based on 60 trading sessions in the selected period.
About Intravenous Infusions Limited
Intravenous Infusions Limited (IIL) is a Ghanaian pharmaceutical manufacturer that produces intravenous fluids, oral rehydration salts, and other medical solutions. The company supplies hospitals, clinics, and healthcare facilities in Ghana and some neighboring West African countries. IIL is one of the few manufacturers of IV fluids in the sub-region, where local production capacity for essential medical supplies remains limited. The company's output is relevant to Ghana's public health infrastructure, particularly in the treatment of dehydration, surgical care, and other hospital-based medical procedures. IIL has faced operational challenges at times, including issues related to production capacity and regulatory compliance.
- Website
- iil.com.gh/
Competitors
Other stocks in the Healthcare & Pharmaceuticals sector.
| Symbol | Price | Day Change |
|---|---|---|
| DASPHARMA | GHS 0.41 | 0.00 (0.00%) |